Angiotensin II receptor blocker/ja: Difference between revisions

@@ Line 68: / Line 68: @@
 ===AT<sub>1</sub>親和性 vs AT<sub>2</sub>親和性===
-<div lang="en" dir="ltr" class="mw-content-ltr">
+特定のARBの結合親和性におけるAT<sub>1</sub>とAT<sub>2</sub>の比を以下に示す。しかし、AT<sub>1</sub>親和性対AT<sub>2</sub>親和性は血圧反応の指標としては意味がない。
-The ratios of AT<sub>1</sub> to AT<sub>2</sub> in binding affinities of the specific ARBs are shown as follows. However, AT<sub>1</sub> affinity vs AT<sub>2</sub> is not a meaningful indicator of blood pressure response.
+* [[Losartan/ja|ロサルタン]]{{snd}} 1000倍
-* [[Losartan]]{{snd}} 1000-fold
+* [[Telmisartan/ja|テルミサルタン]]{{snd}} 3000倍
-* [[Telmisartan]]{{snd}} 3000-fold
+* [[Irbesartan/ja|イルベサルタン]]{{snd}} 8500倍
-* [[Irbesartan]]{{snd}} 8500-fold
+* [[Candesartan/ja|カンデサルタン]]{{snd}} 10000倍以上
-* [[Candesartan]]{{snd}} greater than 10000-fold
+* [[Olmesartan/ja|オルメサルタン]]{{snd}} 12500倍
-* [[Olmesartan]]{{snd}} 12500-fold
+* [[Valsartan/ja|バルサルタン]]{{snd}} 30000倍
-* [[Valsartan]]{{snd}} 30000-fold
+* [[Saprisartan/ja|サプリサルタン]] – ???
-* [[Saprisartan]] – ???
-</div>
 <div lang="en" dir="ltr" class="mw-content-ltr">